Showing 100,041 - 100,060 results of 101,167 for search '(( 5 ((step decrease) OR (nn decrease)) ) OR ( 5 ((a decrease) OR (mean decrease)) ))', query time: 1.90s Refine Results
  1. 100041

    Evaluation of disparities in zinc coverage. by Keith Beam (20700854)

    Published 2025
    “…<div><p>Oral zinc is a proven effective treatment for diarrheal illness, and long-term monitoring is key to evaluating the success of efforts to scale up zinc treatment. …”
  2. 100042

    Table_1_Protective effect of zinc gluconate on intestinal mucosal barrier injury in antibiotics and LPS-induced mice.DOCX by Yongcai Wang (16523067)

    Published 2024
    “…</p>Methods<p>We established a composite mouse model by inducing intestinal mucosal barrier damage using antibiotics and LPS. …”
  3. 100043

    Table_11_Effect of Enteral Immunonutrition in Patients Undergoing Surgery for Gastrointestinal Cancer: An Updated Systematic Review and Meta-Analysis.doc by Jingyi Shen (2464609)

    Published 2022
    “…Compared with the control group, EIN group had a significantly decreased incidence of overall complications (RR = 0.79, p < 0.001). …”
  4. 100044

    Data_Sheet_1_Effect of Enteral Immunonutrition in Patients Undergoing Surgery for Gastrointestinal Cancer: An Updated Systematic Review and Meta-Analysis.DOC by Jingyi Shen (2464609)

    Published 2022
    “…Compared with the control group, EIN group had a significantly decreased incidence of overall complications (RR = 0.79, p < 0.001). …”
  5. 100045
  6. 100046

    Image_1_Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution.TIF by Xianxiong Ma (4276441)

    Published 2021
    “…Moreover, C2 was associated with a lower tumor mutation burden, a decreased neoantigen load, and fewer CNVs. …”
  7. 100047

    Image_12_Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution.TIF by Xianxiong Ma (4276441)

    Published 2021
    “…Moreover, C2 was associated with a lower tumor mutation burden, a decreased neoantigen load, and fewer CNVs. …”
  8. 100048
  9. 100049
  10. 100050

    Table_6_Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution.XLSX by Xianxiong Ma (4276441)

    Published 2021
    “…Moreover, C2 was associated with a lower tumor mutation burden, a decreased neoantigen load, and fewer CNVs. …”
  11. 100051

    An Epitope-Substituted DNA Vaccine Improves Safety and Immunogenicity against Dengue Virus Type 2 by Chung-Tao Tang (764646)

    Published 2015
    “…<div><p>Dengue virus (DENV), a global disease, is divided into four serotypes (DENV1-4). …”
  12. 100052
  13. 100053
  14. 100054
  15. 100055

    Table_9_Effect of Enteral Immunonutrition in Patients Undergoing Surgery for Gastrointestinal Cancer: An Updated Systematic Review and Meta-Analysis.doc by Jingyi Shen (2464609)

    Published 2022
    “…Compared with the control group, EIN group had a significantly decreased incidence of overall complications (RR = 0.79, p < 0.001). …”
  16. 100056

    Image_4_Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution.TIF by Xianxiong Ma (4276441)

    Published 2021
    “…Moreover, C2 was associated with a lower tumor mutation burden, a decreased neoantigen load, and fewer CNVs. …”
  17. 100057

    Table_8_Effect of Enteral Immunonutrition in Patients Undergoing Surgery for Gastrointestinal Cancer: An Updated Systematic Review and Meta-Analysis.doc by Jingyi Shen (2464609)

    Published 2022
    “…Compared with the control group, EIN group had a significantly decreased incidence of overall complications (RR = 0.79, p < 0.001). …”
  18. 100058
  19. 100059

    Image_13_Classification of Estrogen Receptor-Positive Breast Cancer Based on Immunogenomic Profiling and Validation at Single-Cell Resolution.TIF by Xianxiong Ma (4276441)

    Published 2021
    “…Moreover, C2 was associated with a lower tumor mutation burden, a decreased neoantigen load, and fewer CNVs. …”
  20. 100060